Bibliotecas PUC-SP - Busca Integrada

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease

von Juan R. Perea, Juan R. Perea, Alberto Lleó, Alberto Lleó, Daniel Alcolea, Daniel Alcolea, Juan Fortea, Juan Fortea, Jesús Ávila, Jesús Ávila, Marta Bolós, Marta Bolós
Veröffentlicht in Frontiers in Neuroscience (2018-09-01)

HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer’s Disease Pathogenesis

von Carla Borràs, Aina Mercer, Sònia Sirisi, Daniel Alcolea, Joan Carles Escolà-Gil, Francisco Blanco-Vaca, Mireia Tondo
Veröffentlicht in International Journal of Molecular Sciences (2022-08-01)

Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease

von Neus Barranco, Virginia Plá, Daniel Alcolea, Irene Sánchez-Domínguez, Reiner Fischer-Colbrie, Isidro Ferrer, Alberto Lleó, Fernando Aguado
Veröffentlicht in Translational Neurodegeneration (2021-09-01)

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

von Julie Goossens, Alba Cervantes González, Nele Dewit, Laia Lidón, Juan Fortea, Daniel Alcolea, Alberto Lleó, Olivia Belbin, Eugeen Vanmechelen
Veröffentlicht in Alzheimer’s Research & Therapy (2023-10-01)

Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study

von Yanaika S. Hok‐A‐Hin, Katharina Bolsewig, Daimy N. Ruiters, Alberto Lleó, Daniel Alcolea, Afina W. Lemstra, Wiesje M. van derFlier, Charlotte E. Teunissen, Marta delCampo
Veröffentlicht in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2023-07-01)

Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum

von Anna Rennie, Milan Nemy, Cene Jerele, Iñigo Rodríguez-Baz, Victor Montal, Alexandre Bejanin, Milica G Kramberger, Dag Aarsland, Juan Fortea, Alberto Lleó, Eric Westman, Daniel Alcolea, Daniel Ferreira
Veröffentlicht in npj Parkinson's Disease (2025-08-01)

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients

von Matthew Paul Lennol, Irene Sánchez-Domínguez, Inmaculada Cuchillo-Ibañez, Elena Camporesi, Gunnar Brinkmalm, Daniel Alcolea, Juan Fortea, Alberto Lleó, Guadalupe Soria, Fernando Aguado, Henrik Zetterberg, Kaj Blennow, Javier Sáez-Valero
Veröffentlicht in Alzheimer’s Research & Therapy (2022-11-01)

Correction: Diagnostic performance of plasma pTau217, pTau181, Aβ1‑42 and Aβ1‑40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

von Javier Arranz, Nuole Zhu, Sara Rubio-Guerra, Íñigo Rodríguez-Baz, Rosa Ferrer, María Carmona-Iragui, Isabel Barroeta, Ignacio Illán-Gala, Miguel Santos-Santos, Juan Fortea, Alberto Lleó, Mireia Tondo, Daniel Alcolea
Veröffentlicht in Alzheimer’s Research & Therapy (2024-07-01)

Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

von Javier Arranz, Nuole Zhu, Sara Rubio-Guerra, Íñigo Rodríguez-Baz, Rosa Ferrer, María Carmona-Iragui, Isabel Barroeta, Ignacio Illán-Gala, Miguel Santos-Santos, Juan Fortea, Alberto Lleó, Mireia Tondo, Daniel Alcolea
Veröffentlicht in Alzheimer’s Research & Therapy (2024-06-01)

Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies

von David Reyes-Leiva, David Reyes-Leiva, Oriol Dols-Icardo, Oriol Dols-Icardo, Sonia Sirisi, Sonia Sirisi, Elena Cortés-Vicente, Elena Cortés-Vicente, Janina Turon-Sans, Janina Turon-Sans, Noemi de Luna, Noemi de Luna, Rafael Blesa, Rafael Blesa, Olivia Belbin, Olivia Belbin, Victor Montal, Victor Montal, Daniel Alcolea, Daniel Alcolea, Juan Fortea, Juan Fortea, Alberto Lleó, Alberto Lleó, Ricard Rojas-García, Ricard Rojas-García, Ignacio Illán-Gala, Ignacio Illán-Gala
Veröffentlicht in Frontiers in Neurology (2022-01-01)

Disease-Specific Changes in Reelin Protein and mRNA in Neurodegenerative Diseases

von Laia Lidón, Laura Urrea, Franc Llorens, Vanessa Gil, Ignacio Alvarez, Monica Diez-Fairen, Miguel Aguilar, Pau Pastor, Inga Zerr, Daniel Alcolea, Alberto Lleó, Enric Vidal, Rosalina Gavín, Isidre Ferrer, Jose Antonio Del Rio
Veröffentlicht in Cells (2020-05-01)

Challenges associated with biomarker‐based classification systems for Alzheimer's disease

von Ignacio Illán‐Gala, Jordi Pegueroles, Victor Montal, Eduard Vilaplana, María Carmona‐Iragui, Daniel Alcolea, Bradford C. Dickerson, Raquel Sánchez‐Valle, Mony J. deLeon, Rafael Blesa, Alberto Lleó, Juan Fortea, Alzheimer's Disease Neuroimaging Initiative
Veröffentlicht in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2018-01-01)

Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer’s pathophysiological biomarkers

von Alba Cervantes González, Julie Goossens, Elena Vera Campuzano, Isabel Sala, M. Belén Sánchez-Saudinós, Íñigo Rodríguez-Baz, Laia Lidón, Danna Perlaza, Alexandre Bejanin, Annakaisa Haapasalo, Juan Fortea, Daniel Alcolea, Alberto Lleó, Eugeen Vanmechelen, Olivia Belbin
Veröffentlicht in Alzheimer’s Research & Therapy (2025-02-01)

Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia

von Constance Delaby, Daniel Alcolea, Germain Busto, Audrey Gabelle, Xavier Ayrignac, Karim Bennys, Elena Muiño, Paula Villatoro, Israel Fernández-Cadenas, Nicolas Pradeilles, Shaima El Bounasri, Soraya Torres, Christophe Hirtz, Henrik Zetterberg, Alberto Lleó, Juan Fortea, Sylvain Lehmann
Veröffentlicht in Alzheimer’s Research & Therapy (2025-02-01)

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse

von Daniel Alcolea, Jordi Pegueroles, Laia Muñoz, Valle Camacho, Diego López‐Mora, Alejandro Fernández‐León, Nathalie Le Bastard, Els Huyck, Alicia Nadal, Verónica Olmedo, Frederic Sampedro, Victor Montal, Eduard Vilaplana, Jordi Clarimón, Rafael Blesa, Juan Fortea, Alberto Lleó
Veröffentlicht in Annals of Clinical and Translational Neurology (2019-09-01)

Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests

von Bessy Benejam, Laura Videla, Eduard Vilaplana, Isabel Barroeta, Maria Carmona‐Iragui, Miren Altuna, Silvia Valldeneu, Susana Fernandez, Sandra Giménez, Florencia Iulita, Diana Garzón, Alexandre Bejanin, David Bartrés‐Faz, Sebastià Videla, Daniel Alcolea, Rafael Blesa, Alberto Lleó, Juan Fortea
Veröffentlicht in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2020-01-01)

Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD

von Maria Camila Gonzalez, Linn Oftedal, Johannes Lange, Diego Alejandro Tovar‐Rios, Ole‐Bjørn Tysnes, Claire Paquet, Marta Marquié, Mercè Boada, Daniel Alcolea, Konrad Rejdak, Ewa Papuc, Jakub Hort, Cristian Falup‐Pecurariu, Dag Aarsland, Guido Alves, Jodi Maple‐Grødem
Veröffentlicht in Annals of Clinical and Translational Neurology (2025-05-01)

Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy

von Anna M. De Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H. B. M. Schreuder, Catharina J. M. Klijn, Alberto Lleó, Jurgen A. H. R. Claassen, Marcel M. Verbeek
Veröffentlicht in Alzheimer’s Research & Therapy (2021-11-01)

Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4

von Carla Borràs, Marina Canyelles, David Santos, Noemí Rotllan, Estefanía Núñez, Jesús Vázquez, Daniel Maspoch, Mary Cano-Sarabia, Qi Zhao, Maria Carmona-Iragui, Sònia Sirisi, Alberto Lleó, Juan Fortea, Daniel Alcolea, Francisco Blanco-Vaca, Joan Carles Escolà-Gil, Mireia Tondo
Veröffentlicht in Journal of Lipid Research (2025-08-01)

Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy

von Anna M. De Kort, H. Bea Kuiperij, Daniel Alcolea, Iris Kersten, Alexandra A. M. Versleijen, Steven M. Greenberg, Erik Stoops, Floris H. B. M. Schreuder, Catharina J. M. Klijn, Alberto Lleó, Jurgen A. H. R. Claassen, Marcel M. Verbeek
Veröffentlicht in Alzheimer’s Research & Therapy (2021-09-01)